Temocaprilum
Temocaprilum Uses, Dosage, Side Effects, Food Interaction and all others data.
Temocaprilum is a prodrug-type angiotensin-I converting enzyme (ACE) inhibitor not approved for use in the United States, but is approved in Japan and South Korea. Temocaprilum can also be used in hemodialysis patients without risk of serious accumulation.
Temocaprilum is a prodrug of its active metabolite (and diacid form) temocaprilat which contains a thiazepine ring. Temocaprilumat has slightly higher potency than enalaprilat in ACE inhibition isolated from rabbit lung. ACE inhibitors exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.). When compared with other Angiotensin-converting Enzyme Inhibitors, temocapril's advantages include a rapid onset of action and what research suggests is tighter vascular ACE binding than enalaprilat.
Trade Name | Temocaprilum |
Generic | Temocapril |
Temocapril Other Names | Temocapril, Temocaprilum |
Type | |
Formula | C23H28N2O5S2 |
Weight | Average: 476.609 Monoisotopic: 476.143963396 |
Protein binding | 99.5%, including those with renal impairment. |
Groups | Experimental, Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Temocaprilum is an ACE inhibitor primarily indicated in the treatment of hypertension and congestive heart failure, diabetic nephropathy, and improvement of prognosis for coronary artery diseases (including acute myocardial infarction).
Toxicity
In rats, whether or male or female, the LD50 values of temocapril were higher than 5000 mg/kg.
Elimination Route
Temocaprilum is rapidly absorbed in the gastrointestinal tract and converted into the diacid (active) metabolite, which inhibits ACE in plasma.
Half Life
13.1 hours in patients with normal liver function.
Clearance
19.4% urinary recovery.
Elimination Route
Temocaprilum is eliminated primarily through the liver and kidneys.
Innovators Monograph
You find simplified version here Temocaprilum